MilliporeSigma™ Calbiochem™ InhibitorSelect™ IGF Signaling Pathway Inhibitor Panel

Description

• A panel containing 13 potent, selective, reversible and cell-permeable inhibitors, 1 potent, selective and reversible inhibitor, and 1 potent, selective, irreversible and cell-permeable inhibitor useful for the study of multiple signaling pathways activated by IGF: 1 mg of AG1024 (Cat
• No
• 121767); 1 mg of Akt Inhibitor IV (Cat
• No
• 124011); 1 mg of Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 (Cat
• No
• 124018); 1 mg of AMPK Inhibitor, Compound C (Cat
• No
• 171260); 10 mg of bpVphen (Cat
• No
• 203695); 1 mg of ERK Inhibitor, FR180204 (Cat
• No
• 328007); 5 mg of GSK-3β Inhibitor VIII (Cat
• No
• 361549); 1 mg of IGF-1R Inhibitor, PPP (Cat
• No
• 407247); 5 mg of NBI-31772 (Cat
• No
• 479830); 5 mg of PD 98059 (Cat
• No
• 513000); 1 mg of PI-103 (Cat
• No
• 528100); 500μg of PKCβ Inhibitor (Cat
• No
• 539654); 100μg of Rapamycin (Cat
• No
• 553210); 1 mg of RSK Inhibitor, SL0101 (Cat
• No
• 559285); 1 mg of ZM 336372 (Cat
• No
• 692000)
• Also provided with 15mL of anhydrous DMSO (Cat
• No
• KP31817).